Mieke Sprangers

1.2k total citations
13 papers, 551 citations indexed

About

Mieke Sprangers is a scholar working on Public Health, Environmental and Occupational Health, Genetics and Hematology. According to data from OpenAlex, Mieke Sprangers has authored 13 papers receiving a total of 551 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Public Health, Environmental and Occupational Health, 6 papers in Genetics and 6 papers in Hematology. Recurrent topics in Mieke Sprangers's work include Acute Lymphoblastic Leukemia research (8 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Chronic Myeloid Leukemia Treatments (6 papers). Mieke Sprangers is often cited by papers focused on Acute Lymphoblastic Leukemia research (8 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Chronic Myeloid Leukemia Treatments (6 papers). Mieke Sprangers collaborates with scholars based in Germany, United States and Netherlands. Mieke Sprangers's co-authors include Stefan Kostense, Jaap Goudsmit, Menzo Havenga, Wouter Koudstaal, Ronald Vogels, Niklas Feldhahn, Florian Klein, Markus Müschen, Hassan Jumaa and Jana L. Mooster and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Blood.

In The Last Decade

Mieke Sprangers

13 papers receiving 540 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mieke Sprangers Germany 10 257 186 140 139 138 13 551
Susan M. Cleveland United States 13 76 0.3× 186 1.0× 62 0.4× 128 0.9× 108 0.8× 19 462
Yanto Lunardi-Iskandar United States 15 167 0.6× 311 1.7× 134 1.0× 281 2.0× 408 3.0× 27 947
Evelien Naessens Belgium 13 93 0.4× 213 1.1× 118 0.8× 294 2.1× 60 0.4× 26 620
David Bockstoce United States 7 111 0.4× 153 0.8× 67 0.5× 223 1.6× 98 0.7× 8 500
Francisco Garcia‐Pons France 11 174 0.7× 301 1.6× 39 0.3× 530 3.8× 194 1.4× 12 808
R M Hesselton United States 11 183 0.7× 126 0.7× 83 0.6× 389 2.8× 129 0.9× 13 710
Paula Ladne United States 8 114 0.4× 562 3.0× 77 0.6× 131 0.9× 77 0.6× 10 951
Emanuele Marchi United Kingdom 15 77 0.3× 242 1.3× 59 0.4× 350 2.5× 152 1.1× 28 887
C. Moroz Israel 11 71 0.3× 140 0.8× 55 0.4× 164 1.2× 53 0.4× 47 541
Jean‐Gerard Guillet France 13 104 0.4× 132 0.7× 47 0.3× 493 3.5× 97 0.7× 23 706

Countries citing papers authored by Mieke Sprangers

Since Specialization
Citations

This map shows the geographic impact of Mieke Sprangers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mieke Sprangers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mieke Sprangers more than expected).

Fields of papers citing papers by Mieke Sprangers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mieke Sprangers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mieke Sprangers. The network helps show where Mieke Sprangers may publish in the future.

Co-authorship network of co-authors of Mieke Sprangers

This figure shows the co-authorship network connecting the top 25 collaborators of Mieke Sprangers. A scholar is included among the top collaborators of Mieke Sprangers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mieke Sprangers. Mieke Sprangers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Duy, Cihangir, Mieke Sprangers, Lars Klemm, et al.. (2009). Inactivation of Pre-B Cell Receptor-Mediated Tumor Suppression by Aberrant Splicing in Ph+ Acute Lymphoblastic Leukemia.. Blood. 114(22). 579–579. 1 indexed citations
2.
Duy, Cihangir, Lars Klemm, Rahul Nahar, et al.. (2008). Aberrant Splicing of the SLP65 SH2 Domain Enables Pre-B Cell Transformation and Compromises the Leukemia-Suppressive Function of the Pre-B Cell Receptor. Blood. 112(11). 294–294. 1 indexed citations
3.
Sprangers, Mieke, Niklas Feldhahn, Stefanie Liedtke, et al.. (2006). SLP65 deficiency results in perpetual V(D)J recombinase activity in pre-B-lymphoblastic leukemia and B-cell lymphoma cells. Oncogene. 25(37). 5180–5186. 12 indexed citations
4.
Sprangers, Mieke, Niklas Feldhahn, Sebastian Herzog, et al.. (2006). The SRC family kinase LYN redirects B cell receptor signaling in human SLP65-deficient B cell lymphoma cells. Oncogene. 25(36). 5056–5062. 10 indexed citations
5.
Klein, Florian, Niklas Feldhahn, Jana L. Mooster, et al.. (2005). Tracing the Pre-B to Immature B Cell Transition in Human Leukemia Cells Reveals a Coordinated Sequence of Primary and Secondary IGK Gene Rearrangement, IGK Deletion, and IGL Gene Rearrangement. The Journal of Immunology. 174(1). 367–375. 34 indexed citations
6.
Klein, Florian, Niklas Feldhahn, Sebastian Herzog, et al.. (2005). BCR–ABL1 induces aberrant splicing of IKAROS and lineage infidelity in pre-B lymphoblastic leukemia cells. Oncogene. 25(7). 1118–1124. 44 indexed citations
7.
Feldhahn, Niklas, Paula Rı́o, Stefanie Liedtke, et al.. (2005). Deficiency of Bruton's tyrosine kinase in B cell precursor leukemia cells. Proceedings of the National Academy of Sciences. 102(37). 13266–13271. 40 indexed citations
8.
Feldhahn, Niklas, Florian Klein, Jana L. Mooster, et al.. (2005). Mimicry of a constitutively active pre–B cell receptor in acute lymphoblastic leukemia cells. The Journal of Experimental Medicine. 201(11). 1837–1852. 57 indexed citations
9.
Ophorst, Olga, Stefan Kostense, Jaap Goudsmit, et al.. (2004). An adenoviral type 5 vector carrying a type 35 fiber as a vaccine vehicle: DC targeting, cross neutralization, and immunogenicity. Vaccine. 22(23-24). 3035–3044. 63 indexed citations
11.
Kostense, Stefan, Wouter Koudstaal, Mieke Sprangers, et al.. (2004). Adenovirus types 5 and 35 seroprevalence in AIDS risk groups supports type 35 as a vaccine vector. AIDS. 18(8). 1213–1216. 131 indexed citations
12.
Sprangers, Mieke, Wouter Koudstaal, Ronald Vogels, et al.. (2003). Quantifying Adenovirus-Neutralizing Antibodies by Luciferase Transgene Detection: Addressing Preexisting Immunity to Vaccine and Gene Therapy Vectors. Journal of Clinical Microbiology. 41(11). 5046–5052. 145 indexed citations
13.
Llorente, Alicia, Kristian Prydz, Mieke Sprangers, et al.. (2001). Proteoglycan synthesis is increased in cells with impaired clathrin-dependent endocytosis. Journal of Cell Science. 114(2). 335–343. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026